The SCLtTA/BCR-ABL (hereafter referred to as BCR-ABL) mouse in B6 background is a CP CML model that expresses BCR-ABL under the SCL promoter upon tetracycline withdrawal (i.e., tet-off)26–28. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.